0001161697-24-000055.txt : 20240131 0001161697-24-000055.hdr.sgml : 20240131 20240131170128 ACCESSION NUMBER: 0001161697-24-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240130 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCENANY PATRICK J CENTRAL INDEX KEY: 0000929985 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24583799 MAIL ADDRESS: STREET 1: C/O THERMOGENESIS CORP STREET 2: 2711 CITRUS ROAD CITY: RANCHO CORDOVA STATE: CA ZIP: 95742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 01-30-2024 X0508 4 2024-01-30 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0000929985 MCENANY PATRICK J 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 1 0 0 1 Chairman of Board of Directors 0 Common Stock, par value $0.001 per share 2024-01-30 4 M 0 26333 A 4411589 D Common Stock, par value $0.001 per share 2024-01-30 4 M 0 116667 A 4528256 D Restricted Stock Units 2024-01-30 4 M 0 26333 0 D Common Stock 26333 2709412 D Restricted Stock Units 2024-01-30 4 M 0 116667 0 D Common Stock 116667 2592745 D Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. Pursuant to a Separation Agreement between the Company and the Reporting Person, the Reporting Person's restricted stock units that would have vested within the fifteen month period following January 1, 2024 immediately vested. Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The shares were delivered on January 30, 2024. /s/ Patrick J. McEnany 2024-01-31